Business

Repligen Appoints Jason K. Garland as Chief Financial Officer

WALTHAM, Mass., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership,

articleRepligen CorporationSeptember 12, 20235/company/repligen-corporation/news/repligen-appoints-jason-k-garland-as-chief-financial-officer-2023-09-12
Repligen Appoints Jason K. Garland as Chief Financial Officer

About this update from Repligen Corporation

[{"type":"text","content":"WALTHAM, Mass., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has appointed Jason K. Garland as Chief Financial Officer (“CFO”), effective September 25, 2023. Mr. Garland is joining Repligen from his most recent role with medical device outsource (MDO) manufacturer Integer Holdings Corporation (“Integer”), where he served for nearly five years (2018-2023) as Executive Vice President and CFO. He succeeds retiring CFO Jon K. Snodgres, who joined the Company in June 2014 and will continue in a full-time advisory role until his October 6, working closely with Mr. Garland to ensure a smooth transition. In this strategic CFO role, Mr. Garland will act as a key partner to the business, with responsibility for all corporate finance and audit functions, capital markets and M&A transactions, financial planning and analysis, budgeting and risk management. He brings to the Company more than 25 years of relevant experience at large, multi-site organizations experiencing strong growth. This includes a division-level role within General Electric Company (“GE”) where he served as the CFO of a $4 billion dollar business with over 40 global manufacturing sites. In his most recent public company CFO role at Integer, he helped scale the enterprise to $1.4 billion in revenue (2022), and he and his team supported Integer in evaluating and integrating four acquisitions. At Integer, Mr. Garland also assumed executive sponsorship of the company’s Business Process Excellence initiative focused on standardizing and optimizing all non-manufacturing processes. Tony J. Hunt, President and Chief Executive Officer at Repligen, said, “Jason’s financial acumen and rich experience as a business-driven, operational CFO at both large global and growth-focused organizations will serve Repligen well, as we continue to focus on driving success for our company through innovation, including M&A, while delivering above-industry growth and strong financial performance.” He continued, “We thank Jon for his dedicated service to the Company over the past nine years. He has truly been a great partner and instrumental in bringing Repligen to where it is today, and we wish him well in his retirement.” Prior to his role with Integer, Mr. Garland spent three ye...

More updates from Repligen Corporation